KVUE Kenvue Health: Enterprise Value to EBITDA Ratio
The EV/EBITDA dynamics, accounting for debt and amortization, on the GURU.Markets chart for Kenvue Inc. (KVUE) contrast with the pressure from litigation and debt load. Business resilience is based on brand loyalty and raw material supply stability, while efficiency is supported by plant automation. Meanwhile, 12.47 serves as the base value of the parameter, determining the current enterprise value relative to its operating profit.
Comprehensive metric breakdowns and analytics for kenvue.com (KVUE)
- market price and analyst price targets:
- company stock capitalization data:
- business book valuation details:
- debt obligations and liquidity statistics:
- financial results and valuation multiples details:
KVUE - Company Net Income|Future Profit Kenvue Inc.|KVUE - P/E Multiple|Forward P/E Multiple Kenvue Inc.|KVUE - Price to Earnings Adjusted for Growth Rate|Enterprise Value to EBITDA Ratio Kenvue Health|KVUE - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) Kenvue|KVUE - Net earnings per share for the last four quarters|Year-over-year earnings per share growth for the last twelve months kenvue.com|KVUE - Earnings per share growth this year|Earnings growth forecast for next year Kenvue Inc.
Fundamental company analysis:Kenvue Corp KVUE
This multiple compares the total enterprise value of the business with its operating profit before depreciation, taxes, and interest. By analyzing the EV/EBITDA ratio from a historical perspective, an investor determines the fair value of the asset while accounting for the debt load. Such a metric confirms financial stability and the ability to generate a steady cash flow. For Kenvue Inc. (KVUE), this reflects the reliability of a business model that attracts leading experts in the consumer goods market.
Competitor analysis
Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Haleon Group HLN|Verona Pharma Inc. (VRNA) - Company Value to EBITDA|MENS: Enterprise Value to EBITDA Ratio|ligand.com - Enterprise Value to Operating Income Before Depreciation Ratio|AMRX: EV/EBITDA Multiple|Perrigo Company PLC - Business Value to Operating Income Before Depreciation|ALVO (Alvotech Corp) - EV/EBITDA Multiple|Company Value to EBITDA Liquidia Inc. LQDA|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Galapagos NV (GLPG)|ANIP (anipharmaceuticals.com) - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization MannKind MNKD|EV/EBITDA Multiple Amphastar Pharmaceuticals Inc AMPH|Pacira - EV/EBITDA Multiple|Company Value to EBITDA ARS Corp|Theravance Biopharma (TBPH) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to Operating Income Before Depreciation AQST|Enterprise Value to EBITDA Ratio SCPH|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization TECX|Enterprise Value to EBITDA Ratio TNXP (Tonix Pharmaceuticals Inc.)|EV/EBITDA Multiple sxtchina.com (SXTC)|EV/EBITDA Multiple EPRX (Eupraxia Pharmaceuticals Inc.)|bioharvest.com (BHST) - Company Value to EBITDA|EXOZ: Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation ORMP (Oramed Pharmaceuticals)|ENTX: EV/EBITDA Multiple|HYFT - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization ABVC BioPharma|Enterprise Value to Operating Income Before Depreciation CPIX (cumberlandpharma.com)|EV/EBITDA Multiple QNTM|Enterprise Value to EBITDA Ratio FibroGen Inc FGEN|Telomir Pharma - Enterprise Value to EBITDA Ratio|Total Company Value to Operating Income Before Depreciation Ratio Rani Therapeutics Holdings (RANI)|SNYR - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|RLYB - EV/EBITDA Multiple|LEXX (lexariabioscience.com) - Enterprise Value to EBITDA Ratio|PULM (Pulmatrix Inc) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio PTHL|EV/EBITDA Multiple Aptorum|EV/EBITDA Multiple LYRA|IBO - Company Value to EBITDA|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization TNF Pharmaceuticals, Inc. TNFA|YCBD (cbdMD Inc.) - Company Value to Operating Income Before Depreciation Ratio|PainReform Limited - EV/EBITDA Multiple|Business Value to Operating Income Before Depreciation CYTO (Altamira Therapeutics)|LIPO: EV/EBITDA Multiple|optinose.com (OPTN) - EV/EBITDA Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Pieris Pharmaceuticals, Inc.|PROC: Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Petros (PTPI)|Enterprise Value to EBITDA Ratio Qilian International Corp QLI|EV/EBITDA Multiple SLRN (Acelyrin, Inc.)|EV/EBITDA Multiple tffpharma.com TFFP
